Anti-Integrin a2b3 (ITGA2 & ITGB3) Antibody (Tadocizumab)
Catalog No.
F1578
Anti-Integrin a2b3 (ITGA2 & ITGB3) Antibody (Tadocizumab)
Featured Products
Tadocizumab (C4G1; YM-337) is a humanized monoclonal antibody targeting integrin αIIbβ3. Tadocizumab has antiplatelet and antithrombotic effects and can be used in cardiovascular disease research.
Quality Control & DataSheet
- View current batch:
-
Purity > 90% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
145.3 kDa
Dry ice
339086-80-5
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
YM 337, SMART anti-platelet antibody, Tadocizumab (USAN), YM-337
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P17301 & P05106
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
Integrin a2b3 (ITGA2 & ITGB3)
Please avoid freeze-thaw cycles.